medmix specializes in high-precision delivery devices for the healthcare, consumer, and industrial markets. self-described as a global market leader, the company focuses on innovative solutions.

medmix

Analog Devices, Inc. designs, manufactures, tests, and markets integrated circuits (ICs), software, and subsystems that leverage analog, mixed-signal, and digital signal processing technologies. The company provides data converter products, which translate real-world analog signals into digital data, as well as translates digital data into analog signals; power management and reference products for power conversion, driver monitoring, sequencing, and energy management applications in the automotive, communications, industrial, and high-end consumer markets; and power ICs include performance, integration, and software design simulation tools for accurate power supply designs. It also offers high-performance amplifiers to condition analog signals; and radio frequency and microwave ICs to support cellular infrastructure; and microelectromechanical systems technology solutions, including accelerometers used to sense acceleration, gyroscopes for sense rotation, inertial measurement units to sense multiple degrees of freedom, and broadband switches for radio and instrument systems, as well as isolators. In addition, the company offers digital signal processing and system products for high-speed numeric calculations. It serves clients in the industrial, automotive, consumer, instrumentation, aerospace, and communications markets through a direct sales force, third-party distributors, and independent sales representatives in the United States, the rest of North and South America, Europe, Japan, China, and rest of Asia, as well as through its Website. Analog Devices, Inc. was incorporated in 1965 and is headquartered in Wilmington, Massachusetts.

Ray Stata

Analog Devices, Inc.

Cryofab, Inc. provides standard and custom solutions for cryogenic products with applications in life sciences, industrial products, lab ware, public health and safety, medical, food service, biotechnology, superconductivity, semi-conductor, health care, life support, space, research, and energy.

Cryofab, Inc.

Cryostar Industries, Inc. provides laboratory equipment repair, calibration services, and installation specializing in the medical industry and operates in the Tri-State Area. Self-described as providing 24-hour emergency services.

Cryostar Industries, Inc.

medmix is a global provider of high-precision delivery devices, focusing on solutions for healthcare, consumer, and industrial end-markets.

Personal Care Product Manufacturing

GEKA GmbH

Plastics Manufacturing

medmix Industry

Medical Equipment Manufacturing

Haselmeier™ A medmix Brand

medmix - Dental

Medical Device

medmix - Surgery

D-Flex™ Ecosystem

medmix | 25,939 followers on LinkedIn. – medmix is a global leader in high-precision delivery devices across healthcare, consumer and industrial markets. | medmix is a global leader in high-precision delivery devices, with leading positions in healthcare, consumer and industrial end-markets. Our customers benefit from our dedication to innovation and technological advancement that has resulted in over 900 active patents. Our 14 production sites worldwide together with our highly motivated and experienced team of nearly 2’700 employees are at service of our customers with uncompromising quality, proximity and agility. medmix is headquartered in Baar, Switzerland.

Andreas Flick

Group CISO medmix

Daniel Brunner, MBA, CISSP, CISA, CISM, CRISC, CGEIT

CEO medmix Group

René Willi

Juergen Moller

On this World Sustainability Day, we celebrate our #teams from across medmix who volunteer their time, expertise, and energy in support of our local communities. Over the past year, we completed socially impactful projects ranging from #healthawareness campaigns to #recycling drives. Our teams worked on environmental clean-ups and the improvement of biodiversity. We are making a positive difference. Join us as we continue this journey towards sustainability through community engagement and learn more here: https://lnkd.in/dqjsvGJc #sustainability #communityengagement #teamwork

Our journey towards #sustainability has been recognized by the CDP with a Leadership Supplier Engagement Rating (A-). This recognition places us ahead of our industry average and exceeds both the European and global averages. The CDP (formerly Carbon Disclosure Project) is a globally recognized organization that assesses companies’ environmental impacts and efforts. The Supplier Engagement Rating assessment is critical to the transition towards a sustainable Net Zero society and economy. To our teams and our suppliers, THANK YOU for the #engagement and #collaboration . #SustainableInnovation #NetZeroGoals #SustainableEconomy

We are delighted to announce a significant recognition that underscores our commitment to #innovation and #sustainability ! medmix Industry has been named a winner in the 2024 BIG Sustainability Awards, presented by the Business Intelligence Group , for its MIXPAC™ greenLine™ two-component cartridge systems. This recognition complements our recent success at the BIG Innovation Awards in January. Moving forward, our teams are inspired to accelerate our efforts in reducing CO2 emissions globally while developing sustainable solutions that meet the evolving needs of our customers. Learn more at https://lnkd.in/dYCcg_yk #productoftheyear #climateaction #sustainableimpact

Our half-year results are in. René Willi , CEO at medmix , shares “Having met our customers and dedicated teams in all market segments, geographies, and functions, I am convinced that we have all the elements of a global leader in high-precision delivery devices for the healthcare, consumer and industrial end-markets.” Highlights: - Year-on-year organic revenue decline primarily reflects phasing, with improved second half expected in four of five market segments - Improved gross profit margin, while lower volumes impact adjusted EBITDA margin - Increase in reported EBITDA, adjusted operating net cash flow and free cash flow - New ISO-certified Healthcare plant in Atlanta started production on schedule - New guidance: organic revenue growth flat to negative, adjusted EBITDA margin 18% to 19% Read our press release here: https://lnkd.in/gKQdkJRU Read our Half-year report here: https://lnkd.in/gY59Nvgn

“Customer-Centric Innovations” was the motto of our Innovation Day 2024, which took place at medmix Beauty Site in Bechhofen. It was an amazing day, filled with inspiring speeches, engaging discussions, and many creative ideas. Focusing on customer-centricity, the product teams from all business segments presented their latest innovations to our top management and seized the opportunity to collaborate and network with other innovators. Thank you to everyone who contributed to making this day a huge success and fostering our innovation culture at medmix! #innovation #inspiration #customers #leadership

We are excited to share that we have successfully completed the ISO 13485 audit for our new medmix Healthcare site in Atlanta. This facility is our new base for growth and scale for our Drug Delivery, Surgery and Dental segments. Reaching this significant milestone reflects our unwavering commitment to quality and excellence in medical device manufacturing. Achieving ISO 13485 certification ensures that our products consistently meet customer and regulatory requirements, enhancing patient safety and improving overall product performance. A big thank you to our dedicated team for their hard work and diligence in achieving this crucial certification. We look forward to continuing to provide innovative and reliable solutions to our customers. #Healthcare #Haselmeier #DrugDelivery #Surgery #Dental #ISO13485 #MedicalDevice

We are delighted to welcome René Willi as Chief Executive Officer of medmix ! René brings a wealth of industry and leadership experience to power our company's future success. Our mission at medmix is to provide innovative solutions to help millions of people live healthier and more confident lives. Join us in welcoming René Willi as we start an exciting new chapter in our story. #Leadership #Innovation #HealthierLives

We are excited to announce that our legal team has been named "In-house team 2024 in healthcare, life sciences & pharma" at the Legalcommunity.ch . This esteemed recognition is a testament to our legal professionals' unwavering dedication, business mindset, and deep industry expertise. Embodying “Trust & Teamwork", one of our company values, they have been instrumental in navigating complex legal landscapes and providing strategic guidance to support the growth and success of our five business segments. We extend our heartfelt congratulations to each member of our legal team for this well-deserved recognition! For more information, please visit https://lnkd.in/dD4ueb2h #InHouseTeamOfTheYear #Healthcare #Legalcommunitych

We are pleased to report that all proposals of the Board have been approved by our shareholders at medmix ' Annual General Meeting 2024. Moreover, we would like to thank all our shareholders for their continued support and commitment to our company! https://lnkd.in/dq6dCHej

Happy #EarthDay ! While plastics play a significant role in every aspect of day-to-day life, at medmix , we continue to take actions that reduce its negative impact on our planet. In 2023, we launched 20 products based on post-consumer recycled and bio-based resins - actively reducing waste and supporting the circular economy. Learn more about our approach and progress in our Sustainability Review: https://lnkd.in/ddQuXvpQ #EarthDay #Sustainability #Innovation #CircularEconomy

Metric
Company Name	medmix	Analog Devices, Inc.	Cryofab, Inc.	Cryostar Industries, Inc.
Symbol		ADI
MSH ID	SWISS:MEDMIX	COM:ANALOG	COM:CRYOFAB	COM:CRYOSTARINDUSTRIES
Market	PRIVATE	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Technology	Capital Goods & Industrials	Commercial & Professional Services
Industry	Medical Devices	Semiconductors	Manufacturing	Healthcare & Health Services
Country	CH	US	US	US
Stage		Grant
Employee Count	1.00K	26K
Website	medmix.swiss	analog.com	cryofab.com	cryostarindustries.com
LinkedIn	medmix
Founders

Metric
Market Cap		118.26B
Enterprise Value
Monthly Web Traffic	15.86K	2.95M
Web Traffic Growth	-0.52	0.25
Valuation
Raised Capital		4.60M

Metric
Revenue		12.31B
Revenue (LTM)
Revenue (NTM)
Gross Profit		7.88B
EBITDA		6.33B
Operating Income		3.82B
Net Income		3.31B
EPS		6.60
Diluted EPS		6.55
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.62
Operating Profit Margin		0.28
EBITDA Margin		0.51
Net Profit Margin		0.24
Return on Equity		0.08
Return on Assets		0.06
Return on Capital Employed		0.07

SWISS:MEDMIX

medmix

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		29.17
P/B Ratio		2.72
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		12.09
EV Multiple		27.70

Metric
Days Sales Outstanding		43.59
Days Payables Outstanding		40.64
Days Inventory Outstanding		130.57
Operating Cycle		168.33
Cash Conversion Cycle		134.86
Asset Turnover		0.24

Metric
Operating Cash Flow		4.28B
Free Cash Flow		3.06B
Cash Flow to Debt		0.65
Operating Cash Flow/Sales		0.41
Free Cash Flow Yield		0.04

Metric
Cash & Equivalents		1.99B
Accounts Receivable
Inventory		1.45B
Goodwill		26.91B
Debt to Capitalization		0.19
Debt to Assets		0.14
Current Ratio		1.37
Quick Ratio		1.24

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.02
R&D to Revenue		0.13
SG&A to Revenue